> The India Pharmaceuticals Association (IPA) is asking the government to provide financial incentives to active pharmaceutical ingredient makers in hopes of reducing India's reliance on Chinese imports. Story
> CMC Biologics has been contracted by drug developer Portola Pharmaceuticals to manufacture its drug candidate Andexanet alfa, an antidote for Factor Xa inhibitor blood thinners. Release
> Stockholm-based Pharmanest has hired Recipharm Karlskoga to manufacture its drug candidate Shact for treating localized pain related to the the use of IUDs. Release
> Caraco Pharmaceutical Laboratories has recalled 200 vials of the cancer drug Gemcitabine over concerns about sterility. Announcement
> Teva Pharmaceutical Industries ($TEVA) is recalling 9,882 bottles of dextroamphetamine sulfate tablets used to treat ADHD because of impurities. Announcement
> Bausch + Lomb has two recalls totaling 883,597 tubes of sodium chloride ointment because of crystal precipitate that has led to customer complaints that the ointments feel gritty. Notice and Notice
And Finally... The demand for pharmaceutical compliance personnel is soaring in India as the FDA has upped its enforcement there, leading to warning letters and plant bans on some of the country's largest drugmakers. Story